Epitope-based vaccination against pneumonic tularemia
نویسندگان
چکیده
منابع مشابه
An outbreak of primary pneumonic tularemia on Martha's Vineyard.
BACKGROUND In the summer of 2000, an outbreak of primary pneumonic tularemia occurred on Martha's Vineyard, Massachusetts. The only previously reported outbreak of pneumonic tularemia in the United States also occurred on the island in 1978. METHODS We conducted a case-control study of adults with pneumonic tularemia and investigated the environment to identify risk factors for primary pneumo...
متن کاملB Cell Epitope-Based Vaccination Therapy
Currently, many peptide vaccines are undergoing clinical studies. Most of these vaccines were developed to activate cytotoxic T cells; however, the response is not robust. Unlike vaccines, anti-cancer antibodies based on passive immunity have been approved as a standard treatment. Since passive immunity is more effective in tumor treatment, the evidence suggests that limited B cell epitope-base...
متن کاملEpitope-based vaccine against influenza.
The currently available vaccines against influenza are viral strain specific and, hence, their efficacy is limited when the circulating strain is not the one included in them. We review herewith some of the more recently developed influenza vaccines and further describe our own data on the design of epitope-based broad-spectrum vaccine for human use. This vaccine is comprised of recombinant fla...
متن کاملRespiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague.
Mice were vaccinated with a recombinant fusion protein, rF1-V, by an intramuscular prime followed by an intranasal boost, to evaluate protection against pneumonic plague. Forty-two days after the intranasal boost, the mice were challenged by aerosol exposure to Yersinia pestis. Survival after exposure depended upon the dose of rF1-V given i.n. with > or = 80% survival in the highest dose groups...
متن کاملComplete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination
BACKGROUND No efficient vaccine against plague is currently available. We previously showed that a genetically attenuated Yersinia pseudotuberculosis producing the Yersinia pestis F1 antigen was an efficient live oral vaccine against pneumonic plague. This candidate vaccine however failed to confer full protection against bubonic plague and did not produce F1 stably. METHODOLOGY/PRINCIPAL FIN...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vaccine
سال: 2009
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2009.06.101